Operational Infection Disease R&D IDIQ

Closed Solicitation Posted

Solicitation number
N0018924RZ014
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of the Navy Naval Supply Systems Command is seeking proposals for an indefinite delivery indefinite quantity (IDIQ) contract to provide comprehensive scientific research and development services related to operational infectious diseases. The required services may include developing and refining data-related tasking, examining the impact of case management and health care delivery on costs and outcomes, and other research and laboratory testing. The contract will be awarded on a best value trade-off basis, and the non-cost proposal is limited to 30 pages, with requirements for a Federalwide Assurance, insurance, and a DCAA-approved accounting system. Proposals are due by March 25, 2024.

This procurement does not have a set-aside designation. The place of performance is San Diego, CA. The period of performance is a base year with four one-year options. While no specific contract value or budget range is provided, the scope of work indicates the potential for a significant, multi-year research and development effort to support the Naval Health Research Center's Operational Infectious Diseases Directorate.

Notice text

3 versions

Update #3 · Latest ·

This acquisition will involve comprehensive scientific research and development services over the full period of performance. The required acquisition may involve, but will not be limited to: developing, refining, and executing the full spectrum of data-related tasking; examining the impact of case management services and source of delivered health care services on health care costs, patient outcomes, and health care system efficiencies; and more.

Update #2 ·

This acquisition will involve comprehensive scientific research and development services over the full period of performance. The required acquisition may involve, but will not be limited to: developing, refining, and executing the full spectrum of data-related tasking; examining the impact of case management services and source of delivered health care services on health care costs, patient outcomes, and health care system efficiencies; and more.

Amended to Answer the Questions and Answers.

Update #1 ·

This acquisition will involve comprehensive scientific research and development services over the full period of performance. The required acquisition may involve, but will not be limited to: developing, refining, and executing the full spectrum of data-related tasking; examining the impact of case management services and source of delivered health care services on health care costs, patient outcomes, and health care system efficiencies; and more.

Files

File Type Posted
N0018924RZ0140002.pdf PDF
2.06a - N0018924RZ0140001.pdf PDF
PAST_PERFORMANCE_INFORMATION_FORM.docx DOCX document
N0018924RZ014.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Pre-Clinical Models of Infectious Diseases United States · NAICS 541714 National Institute of Allergy and Infectious Diseases No set-aside
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases NAICS 541715 National Institute of Allergy and Infectious Diseases No set-aside
Broad agency announcement - biomedical research and diving equipment development Washington Navy Yard, District of Columbia, United States · NAICS 541714 Naval Sea Systems Command No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity